Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hologic, Inc shares valued at $540,864 were sold by Stamoulis Christiana on Oct 20 ’25. At $73.07 per share, Stamoulis Christiana sold 7,402 shares. The insider’s holdings dropped to 47,336 shares worth approximately $3.56 million following the completion of this transaction.
Also, Stamoulis Christiana purchased 7,402 shares, netting a total of over 540,864 in proceeds.
Before that, MACMILLAN STEPHEN P had sold 138,358 shares from its account. In a trade valued at $9,266,118, the Chairman, President and CEO traded Hologic, Inc shares for $66.97 each. Upon closing the transaction, the insider’s holdings decreased to 138,358 shares, worth approximately $92.77 million.
As published in a research note from Argus on January 12, 2026, Hologic, Inc [HOLX] has been rated down from a Buy to a Hold. Analysts at Evercore ISI downgraded the stock from ‘”an Outperform”‘ to ‘”an In-line”‘ outlook in a report released in early January. As of November 21, 2025, BNP Paribas Exane has decreased its “an Outperform” rating to a “Neutral” for HOLX. Earlier on October 07, 2025, Evercore ISI upgraded its rating. Their new recommendation was “an Outperform” for HOLX stock which previously was a “an In-line”.
Analyzing HOLX Stock Performance
On last trading session, Hologic, Inc [NASDAQ: HOLX] rose 0.04% to $75.14. The stock’s lowest price that day was $74.975, but it reached a high of $75.225 in the same session. During the last five days, there has been a surge of approximately 0.36%. Over the course of the year, Hologic, Inc shares have jumped approximately 7.76%.
Is Hologic, Inc subject to short interest?
Stocks of Hologic, Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.57 million shares to 3.75 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.32 million shares. A decline of -15.22% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.34 of the overall float, the days-to-cover ratio (short ratio) decline to 1.34.
Which companies own the most shares of Hologic, Inc (HOLX)?
In terms of Hologic, Inc share price expectations, FactSet research, analysts set an average price target of 78 in the next 12 months, up nearly 3.85% from the previous closing price of $75.11. Analysts anticipate Hologic, Inc stock to reach 79 by 2026, with the lowest price target being 76. In spite of this, 10 analysts ranked Hologic, Inc stock as Buy at the end of 2026. On August 18, 2025, Argus assigned a price target of “a Buy” to the stock and upgraded coverage with a $80.
